Clinical Trial Update: Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating biomarkers in colorectal cancer patients with native KRAS treated with chemotherapy plus cetuximab; study completed with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Grupo Espanol Multidisciplinario del Cancer Digestivo | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-07-02